Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Endometrial Neoplasms and MTOR[original query] |
|---|
| Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. Journal of cancer research and clinical oncology 2012 Mar 138 (3): 377-85. Wang Li-E, Ma Hongxia, Hale Katherine S, Yin Ming, Meyer Larissa A, Liu Hongliang, Li Jie, Lu Karen H, Hennessy Bryan T, Li Xuesong, Spitz Margaret R, Wei Qingyi, Mills Gordon |
| Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study. Targeted oncology 2012 Dec . Trédan O, Treilleux I, Wang Q, Gane N, Pissaloux D, Bonnin N, Petit T, Cretin J, Bonichon-Lamichhane N, Priou F, Lavau-Denes S, Mari V, Freyer G, Lebrun D, Alexandre J, Ray-Coquard I |
| PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Mar 30 (8): 777-82. Janku Filip, Wheler Jennifer J, Westin Shannon N, Moulder Stacy L, Naing Aung, Tsimberidou Apostolia M, Fu Siqing, Falchook Gerald S, Hong David S, Garrido-Laguna Ignacio, Luthra Rajyalakshmi, Lee J Jack, Lu Karen H, Kurzrock Razel |
| Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Oncotarget 2014 May 5 (10): 3029-38. Wheler Jennifer J, Moulder Stacy L, Naing Aung, Janku Filip, Piha-Paul Sarina A, Falchook Gerald S, Zinner Ralph, Tsimberidou Apostolia M, Fu Siqing, Hong David S, Atkins Johnique T, Yelensky Roman, Stephens Philip J, Kurzrock Razel |
| The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2014 May 24 (4): 713-7. Meyer Larissa A, Slomovitz Brian M, Djordjevic Bojana, Westin Shannon N, Iglesias David A, Munsell Mark F, Jiang Yunyun, Schmandt Rosemarie, Broaddus Russell R, Coleman Robert L, Galbincea John M, Lu Karen |
| Genetic alterations in endometrial cancer by targeted next-generation sequencing. Experimental and molecular pathology 2015 Nov . Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow |
| A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study). Cancer 2016 Sep . Makker Vicky, Recio Fernando O, Ma Ling, Matulonis Ursula A, Lauchle Jennifer O, Parmar Hema, Gilbert Houston N, Ware Joseph A, Zhu Rui, Lu Shan, Huw Ling-Yuh, Wang Yulei, Koeppen Hartmut, Spoerke Jill M, Lackner Mark R, Aghajanian Carol |
| Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer. Oncotarget 2016 Jul . Wei Runmin, De Vivo Immaculata, Huang Sijia, Zhu Xun, Risch Harvey, Moore Jason H, Yu Herbert, Garmire Lana |
| A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding. American journal of human genetics 2016 Jun 98 (6): 1159-69. Painter Jodie N, Kaufmann Susanne, O'Mara Tracy A, Hillman Kristine M, Sivakumaran Haran, Darabi Hatef, Cheng Timothy H T, Pearson John, Kazakoff Stephen, Waddell Nicola, Hoivik Erling A, Goode Ellen L, Scott Rodney J, Tomlinson Ian, Dunning Alison M, Easton Douglas F, French Juliet D, Salvesen Helga B, Pollock Pamela M, Thompson Deborah J, Spurdle Amanda B, Edwards Stacey |
| Identification of novel mutations in endometrial cancer patients by whole-exome sequencing. International journal of oncology 2017 Mar . Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow |
| A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (14): 3253-3262. Bendell Johanna C, Varghese Anna M, Hyman David M, Bauer Todd M, Pant Shubham, Callies Sophie, Lin Ji, Martinez Ricardo, Wickremsinhe Enaksha, Fink Aaron, Wacheck Volker, Moore Kathleen |
| Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study. European journal of cancer care 2019 8 28 (6): e13137. Lupini Laura, Scutiero Gennaro, Iannone Piergiorgio, Martinello Ruby, Bassi Cristian, Ravaioli Noemi, Soave Ilaria, Bonaccorsi Gloria, Lanza Giovanni, Gafà Roberta, Loizzi Vera, Negrini Massimo, Greco Pantal |
| Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations. Cancers 2022 9 14 (17): . Kurzrock Razelle, Aggarwal Charu, Weipert Caroline, Kiedrowski Lesli, Riess Jonathan, Lenz Heinz-Josef, Gandara Dav |
| Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling. Cancers 2023 7 15 (13): . Yinan Wang, Hui Du, Wenkui Dai, Cuijun Bao, Xi Zhang, Yan Hu, Zhiyu Xie, Xin Zhao, Changzhong Li, Wenyong Zhang, Ruifang |
| Race- associated molecular differences in uterine serous carcinoma. Frontiers in oncology 2024 10 14 1445128. Olivia D Lara, Hannah Karpel, Steven Friedman, Kari E Hacker, Bhavana Pothu |
- Page last reviewed:Feb 1, 2024
- Content source: